BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.00
-0.05 (-0.17%)
Mar 25, 2026, 9:57 AM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 742.75 million as of March 24, 2026. Its market cap has decreased by -12.39% in one year.
Market Cap
742.75M
Enterprise Value
715.45M
Revenue
277.12M
Ranking
n/a
PE Ratio
16.60
Stock Price
29.00
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 742.75M, a decrease of -53.02%. That is a compound annual growth rate of -8.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 742.75M | -6.45% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 1.09B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.03B |
| TCI GENE | 965.74M |
| Taiwan Advance Bio-Pharmaceutical | 936.00M |
| NatureWise Biotech & Medicals | 916.55M |
| Neith | 899.73M |
| Eusol Biotech | 822.00M |